Rajesh Asarpota
CIK 1600301 · Chief Financial Officer · last filed 2026-01-28
Rajesh Asarpota is a Chief Financial Officer who has filed 7 SEC Form 4 insider transactions across 4 companies since 2014. The most recent filing, for PFSA, was dated Jan 28, 2026. Current disclosed insider exposure totals $2.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.49M
4
7
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PFSA | Director | — | $0.22 | — | $0 | 1 | 2026-01-28 |
| MRVI | Chief Financial Officer | 500,000 | $4.98 | $2.49M | $0 | 1 | 2025-06-30 |
| NUVASIVE INC (NUVA) Delisted | CFO | — | $39.75 | — | $0 | 2 | 2019-03-05 |
| QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Sr. VP., CFO and PAO | 24,000 | — | — | $0 | 2 | 2014-02-26 |
Recent Filings
7 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-28 | PFSA | Grant (A) | — | $0 | EDGAR |
| 2025-06-30 | MRVI | Grant (A) | +500,000 | $0 | EDGAR |
| 2019-03-05 | NUVASIVE INC (NUVA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-02-07 | NUVASIVE INC (NUVA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-08-18 | — | Disp (D) | −24,000 | $0 | |
| 2014-02-26 | QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Grant (A) | +4,000 | $0 | EDGAR |
| 2014-02-20 | QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Grant (A) | +20,000 | $0 | EDGAR |